CA
About
Accelerate a diverse portfolio of at least 20 high-quality antibacterial products towards clinical development leveraging $250 million in BARDA funds with matching funds from the Wellcome Trust and the AMR Centre.
Investment Focus
- Location
- Boston, US
Contact Information
Find more investors like CARB-X
Search Investors